A Pan-European Alzheimer's Platform - better understand the early stages of Alzheimers disease and prevent dementia before symptoms occur.

PMS-IC is delivering the analytical workspace for balancing recruitment/cohort effectiveness together with co-developing the EPAD engine for new adaptive clinical trials.

This major Initiative is aimed at creating a novel environment for testing interventions targeted at the prevention of Alzheimer’s dementia.

EPAD is a €64m project involving 36 EU partners awarded through the Medicines Initiative.

For more information, see: www.ep-ad.org

Social share


Get in touch to discuss your requirements and get an accurate cost for your project.